Araris Biotech AG
Edit

Araris Biotech AG

https://ararisbiotech.com/
Tags:BioTechBuildingDrugEngineeringMedTechPlatformTechnology
Araris Biotech AG is pioneering a novel linker technology for antibody-drug conjugates (ADCs.) Our linker platform enables the attachment of any payload to ‘off the shelf’ antibodies without the need of prior antibody engineering.
Location: Switzerland, Zurich
Member count: 11-50
Total raised: $43.302355M
Founded date: 2019

Investors 3

Funding Rounds 3

DateSeriesAmountInvestorsDeal News
05.10.2022-$24M-venturelab...
22.10.2020Seed$16.746118...-finsmes.co...
20.08.2019Seed$2.556237M-finsmes.co...

Mentions in press and media 25

DateTitleDescriptionCategoryAuthorSource
04.11.2022The C-suit... From intern to CEO Power ban...Support-startuptic...
05.10.2022Araris Bio...Araris Biotech AG, a AU ZH, Sw...Switzerlan...-finsmes.co...
04.10.2022Araris Bio...AU ZH, SWITZERLAND / October 4...--4biocapita...
04.10.2022Araris Bio.../EIN News/ -- ZURICH, Switzerl...--einpresswi...
04.10.2022Araris Bio...ZURICH, Switzerland, Oct. 04, ...--globenewsw...
04.10.2022Araris Bio...Araris Biotech closes USD 24 m...--venturelab...
04.10.2022Araris Bio... Araris’ linker platform enab...Financing-startuptic...
08.02.20221100 Quadr... Erst im vergangenen Jahr gab...Expansion ...-startuptic...
22.10.2020Araris Bio...Araris Biotech raises CHF 15.2...--venturelab...
22.10.20204BIO Capit...· Dmitry Kuzmin, Managing Part...--4biocapita...
Show more